{
  "id": 18280860,
  "title": "Pharmacy Board Warns Against Using Cetirizine for Vaginal Tightening, Dryness",
  "url": "https://urgent.news/2026/11/05/pharmacy-board-warns-against-using-cetirizine-for-vaginal-tightening",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-05T08:18:11.000Z",
  "source": {
    "name": "Capital FM Kenya",
    "slug": "capital-fm-kenya",
    "url": "https://capitalfm.africa/pharmacy-board-warns-against-using-cetirizine-for-vaginal-tightening-dryness/"
  },
  "original_language": "en",
  "account": "The Pharmacy and Poisons Board (PPB) of Kenya has issued a warning against the misuse of cetirizine tablets for vaginal tightening or drying purposes. The Board emphasized that claims circulating on social media suggesting cetirizine, an antihistamine used to treat allergic conditions, can be applied to vaginal areas are unscientific and unsupported. Cetirizine is a medication meant for oral use only, prescribed to manage allergic reactions such as allergic rhinitis and urticaria (hives). It should be consumed orally, following the dosage and instructions given by a healthcare professional. The Board cautioned that inserting cetirizine tablets into the vagina could lead to irritation, burning, soreness, pain, and discomfort. It also highlighted that consuming cetirizine in inappropriate ways could disrupt the vagina’s natural protective environment, raising the risk of infections. The regulator cautioned against taking higher-than-recommended doses of the drug orally, noting that an overdose could lead to symptoms such as excessive sleepiness, dizziness, fatigue, restlessness, confusion, shaking, rapid heartbeat, and difficulty urinating. The PPB urged the public not to insert cetirizine or any other oral medication into the vagina, cautioning against trusting unverified social media claims about reproductive and sexual health. The Board also advised patients not to exceed the recommended cetirizine dosage and to use the medicine solely for its approved purposes and through the prescribed route. If individuals experience vaginal dryness or other sexual and reproductive health issues, they are advised to consult a qualified healthcare professional instead of experimenting with unapproved remedies. The safety notice was authored by PPB Chief Executive Officer Dr Ahmed I. Mohamed on November 4, 2026. The warning coincides with increasing worries about health misinformation spreading on social media, including claims about the unapproved use of medicines for intimate and reproductive health.",
  "summary": "In a safety alert, the Board dismissed claims suggesting that cetirizine, an antihistamine used to relieve allergic conditions, can be used for vaginal purposes.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}